Search

everythinglearnresearchcommunity

for

Search:↓

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Scientists created a 3D skin model to study a chronic skin disease and test treatments.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

3D cell cultures are better for testing hair growth treatments than 2D cultures.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

The Spherical Skin Model improves drug and cosmetic testing by accurately mimicking human skin for efficient compound screening.

Topical metformin shows promise for skin treatments but needs more testing for safety and effectiveness.

Biomagnetic forces can deform red blood cells.

A new mouse model effectively mimics vitiligo for research and drug testing.